| The third international consensus definitions for sepsis and septic shock (Sepsis-3) M Singer, CS Deutschman, CW Seymour, M Shankar-Hari, D Annane, ... Jama 315 (8), 801-810, 2016 | 25629 | 2016 |
| Surviving sepsis campaign: international guidelines for management of sepsis and septic shock: 2016 A Rhodes, LE Evans, W Alhazzani, MM Levy, M Antonelli, R Ferrer, ... Intensive care medicine 43, 304-377, 2017 | 10644 | 2017 |
| Global, regional, and national sepsis incidence and mortality, 1990–2017: analysis for the Global Burden of Disease Study KE Rudd, SC Johnson, KM Agesa, KA Shackelford, D Tsoi, DR Kievlan, ... The Lancet 395 (10219), 200-211, 2020 | 4838 | 2020 |
| Assessment of clinical criteria for sepsis: for the third international consensus definitions for sepsis and septic shock (Sepsis-3) CW Seymour, VX Liu, TJ Iwashyna, FM Brunkhorst, TD Rea, A Scherag, ... Jama 315 (8), 762-774, 2016 | 4278 | 2016 |
| Developing a new definition and assessing new clinical criteria for septic shock: for the Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3) M Shankar-Hari, GS Phillips, ML Levy, CW Seymour, VX Liu, ... Jama 315 (8), 775-787, 2016 | 2517* | 2016 |
| Time to treatment and mortality during mandated emergency care for sepsis CW Seymour, F Gesten, HC Prescott, ME Friedrich, TJ Iwashyna, ... New England Journal of Medicine 376 (23), 2235-2244, 2017 | 1972 | 2017 |
| Incidence and trends of sepsis in US hospitals using clinical vs claims data, 2009-2014 C Rhee, R Dantes, L Epstein, DJ Murphy, CW Seymour, TJ Iwashyna, ... Jama 318 (13), 1241-1249, 2017 | 1600 | 2017 |
| Interleukin-6 receptor antagonists in critically ill patients with Covid-19–preliminary report Remap-Cap Investigators, AC Gordon, PR Mouncey, F Al-Beidh, ... MedRxiv, 2021.01. 07.21249390, 2021 | 1360 | 2021 |
| Derivation, validation, and potential treatment implications of novel clinical phenotypes for sepsis CW Seymour, JN Kennedy, S Wang, CCH Chang, CF Elliott, Z Xu, S Berry, ... Jama 321 (20), 2003-2017, 2019 | 989 | 2019 |
| Effect of hydrocortisone on mortality and organ support in patients with severe COVID-19: the REMAP-CAP COVID-19 corticosteroid domain randomized clinical trial DC Angus, L Derde, F Al-Beidh, D Annane, Y Arabi, A Beane, ... Jama 324 (13), 1317-1329, 2020 | 849 | 2020 |
| The global burden of sepsis: barriers and potential solutions KE Rudd, N Kissoon, D Limmathurotsakul, S Bory, B Mutahunga, ... Critical care 22, 1-11, 2018 | 337 | 2018 |
| Association between the New York sepsis care mandate and in-hospital mortality for pediatric sepsis IVR Evans, GS Phillips, ER Alpern, DC Angus, ME Friedrich, N Kissoon, ... Jama 320 (4), 358-367, 2018 | 327 | 2018 |
| Severe sepsis in pre-hospital emergency care: analysis of incidence, care, and outcome CW Seymour, TD Rea, JM Kahn, AJ Walkey, DM Yealy, DC Angus American journal of respiratory and critical care medicine 186 (12), 1264-1271, 2012 | 318 | 2012 |
| Hypercoagulation and antithrombotic treatment in coronavirus 2019: a new challenge F Violi, D Pastori, R Cangemi, P Pignatelli, L Loffredo Thrombosis and haemostasis 120 (06), 949-956, 2020 | 285 | 2020 |
| Current murine models of sepsis AJ Lewis, CW Seymour, MR Rosengart Surgical infections 17 (4), 385-393, 2016 | 277 | 2016 |
| Septic shock: advances in diagnosis and treatment CW Seymour, MR Rosengart Jama 314 (7), 708-717, 2015 | 214 | 2015 |
| Association of the quick sequential (sepsis-related) organ failure assessment (qSOFA) score with excess hospital mortality in adults with suspected infection in low-and middle … KE Rudd, CW Seymour, AR Aluisio, ME Augustin, DS Bagenda, A Beane, ... Jama 319 (21), 2202-2211, 2018 | 205 | 2018 |
| Critical care bed growth in the United States. A comparison of regional and national trends DJ Wallace, DC Angus, CW Seymour, AE Barnato, JM Kahn American journal of respiratory and critical care medicine 191 (4), 410-416, 2015 | 205 | 2015 |
| The outcome of extubation failure in a community hospital intensive care unit: a cohort study CW Seymour, A Martinez, JD Christie, BD Fuchs Critical care 8, 1-6, 2004 | 205 | 2004 |
| Effect of convalescent plasma on organ support–free days in critically ill patients with COVID-19: a randomized clinical trial H Abdelhady, M Abdelrazik, Z Abdi, D Abdo, A Abdulle, L Abel, ... Jama 326 (17), 1690-1702, 2021 | 195 | 2021 |
